18 results
8-K
EX-99.2
BIO
Bio-Rad Laboratories Inc. - Ordinary Shares
25 Feb 22
Regulation FD Disclosure
9:19am
processing product families, deeper penetration in the biopharma segment, and cell biology innovation. The Clinical Diagnostics segment designs, manufactures
8-K
EX-99.1
BIO
Bio-Rad Laboratories Inc. - Ordinary Shares
25 Feb 22
Regulation FD Disclosure
9:19am
that advance scientific discovery and improve healthcare INVOLVEMENT INTEGRITY INNOVATION INDEPENDENCE
Investment Thesis Well established company with a strong … in life science research and clinical diagnostics 70 $2.9B 7,900 Years Strong Annual Sales* Employees Worldwide Performance Continuous Innovation
8-K
EX-99.2
BIO
Bio-Rad Laboratories Inc. - Ordinary Shares
10 Dec 20
Regulation FD Disclosure
5:21pm
, Bio-Rad President and Chief Executive Officer. “We continue our efforts to balance our investment in innovation with our continued operating … in innovation with our continued operating discipline; believing these efforts support our mission to advance the discovery process and improve healthcare
8-K
EX-99.1
BIO
Bio-Rad Laboratories Inc. - Ordinary Shares
10 Dec 20
Regulation FD Disclosure
5:21pm
& BUSINESS MODEL & INNOVATION Responsibility (CSR) & Environmental, Social, and Corporate Governance (ESG) GOVERNANCE values and goals Product Design … Labeling ü Develop strong positioning and proactive messaging of our Corporate Social LEADERSHIP & BUSINESS MODEL & INNOVATION Responsibility (CSR
424B2
rea dznst3
7 Dec 10
Prospectus for primary offering
12:00am
424B5
bseyqj5cum4ep5j sxh
6 Dec 10
Prospectus supplement for primary offering
12:00am
424B3
zhy inh0m4
2 Jun 00
Prospectus supplement
12:00am
S-4
q7ri4cv13sz5
17 May 00
Registration of securities issued in business combination transactions
12:00am
- Prev
- 1
- Next